News
NHS launches ‘subscription’ scheme for antibiotics with pharma sector
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse The NHS will agree subscription-style deals with drugmakers for antibiotics, as the UK seeks to enco...
Read moreAMR Industry Alliance Will Attend the 10th Annual World AMR Congress
Geneva – July 3rd, 2024 – The AMR Industry Alliance is pleased to attend the 10th Annual World AMR Congress in the lead-up to the UN High-Level Meeting on antimicrobial resistance. The Congress wi...
Read moreGlobal Health Leaders Unite to Confront Urgent Public Health Crisis of Antimicrobial Resistance
The Global AMR Diary to ignite awareness and catalyze action to shape policy and saves lives GENEVA -- MAY 7, 2024 -- The Partnership to Fight Infectious Disease (PFID) and a collective...
Read moreAMR Industry Alliance Launches 2024 Equitable and Responsible Access Roadmap
The AMR Industry Alliance released its Equitable & Responsible Access Roadmap highlighting key barriers to diagnostics and antimicrobial access -- and outlining solutions to tackle the barriers o...
Read moreAMR Industry Alliance Launches New Report on Role of Diagnostics in National Action Plans
Geneva – April 30, 2024 – A new report from the AMR Industry Alliance examines the role of diagnostics in national action plans (NAPs) and highlights successful examples integrating and implementi...
Read moreLeaving the Lab: Tracking the Decline in AMR R&D Professionals
The AMR Industry Alliance conducted a review of publicly available data on the state of AMR research and development talent. It found that: The AMR R&D workforce is limited and declining. It...
Read moreAMR Industry Alliance Contributions to Responsible Antibiotic Manufacturing
The report is based on independent, quality assured research conducted by RAND Europe and funded by the AMR Industry Alliance. Please note the supporting annexes accompanying our research rep...
Read moreExperts Discuss the Creation of a Manufacturing Standard during World AMR Awareness Week
On the occasion of World AMR Awareness Week, Courtney Soulsby from BSI and Steve Brooks from the AMR Industry Alliance discuss action-oriented progress on AMR in the environment. Listen in to l...
Read moreWorld AMR Awareness Week 2023
In recognition of 2023 World Antimicrobial Awareness Week, the AMR Industry Alliance held two webinars: Multistakeholder Engagement in the Fight against AMR – Increasing Responsible...
Read moreThe Power of Partnership to Address Antimicrobial Resistance
Antimicrobial Resistance (AMR) is a significant threat to global health and economic development. As the progression of AMR renders antibiotics less effective, common infections, such as...
Read moreSandoz, Teva Certified as Meeting Responsible Antibiotic Manufacturing Standard
The British Standards Institution (BSI) announced today that drugmakers Sandoz and Teva have become the first companies to be certified as meeting an international standard for responsible antibio...
Read moreSandoz and Teva Achieve First-Of-A-Kind Manufacturing Certification
In their commitment to tackling global antimicrobial resistance (AMR), the first two Pharma companies have gained independent certification in responsible antibiotic manufacturing. Sandoz and Teva...
Read moreSandoz and Teva Achieve Independent Certification for Steps to Minimise Antimicrobial Resistance Risk
Certification demonstrates their commitment to protecting people and planet 9 November – Sandoz and TEVA have become the first organizations to be certified as meeting an international stand...
Read moreAMR Industry Alliance Opens Applications for 2023 Stewardship Prize
The AMR Industry Alliance is pleased to announce that is now accepting applications for its annual Stewardship Prize. The Stewardship Prize is an initiative to identify and recognize innovative approaches to combatting antimicrobial resistance (AMR) in low-to-moderate-income countries
Read moreAMR Certification: Recognising Responsibly in Antibiotic Manufacture
Following the recent launch of the BSI’s AMR certification, EPR invited Steve Brooks from the AMR Industry Alliance and BSI’s Courtney Soulsby to elucidate its significance for antibiotic manufact...
Read moreNew AMR Certification Launched for Antibiotic Manufacturers
Following publication of the Antibiotic Manufacturing Standard in 2022 to help overcome AMR, antibiotic manufacturers can now verify their actions through a new certification. This...
Read moreTo Push Antibiotic Makers to Be More Green, a New System Will Certify Manufacturing Practices
This article first appeared in STAT. In response to concerns about pollution caused by antibiotic production, an industry group is launching a new system to certify that manufacturers mee...
Read moreNew Certification System Could Promote Responsible Antibiotic Manufacturing
This article was originally published by the Center for Infectious Disease Policy and Research (CIDRAP). A new certification scheme launched today aims to minimize the environ...
Read moreVerifying Antibiotics Supply Chain Standards
This article was originally published in POLITICO Pro Morning Health Care. From today, manufacturers of antibiotics and their raw ingredients can apply for a new certificate that proves t...
Read moreAMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification
BSI Certification Is Open To Any Manufacturer, For Any Drug Executive Summary A new voluntary certification from the AMR Industry Alliance and the British Standards Institution will asse...
Read moreNew Certification Aims to Mitigate Antimicrobial Resistance in Antibiotic Manufacturing
Certification launched to demonstrate the responsible manufacturing of antibiotics and address environmental waste concerns LONDON, June 5, 2023 /PRNewswire/ -- BSI, the business improvement...
Read moreNew Certification Aims to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
Certification launched to demonstrate the responsible manufacturing of antibiotics and address environmental waste concerns London, UK -- BSI, the business improvement and standards company, today...
Read morePollution from Antibiotic Factories Highlighted as Public Health Risk
This article first appeared in the Financial Times When some public-spirited Indian military veterans decided to examine the water quality in the Sirsa and Sutlej rivers, in the northern state of H...
Read moreAMR Industry Alliance Releases 2022 Annual Report
New York, NY The AMR Industry Alliance is pleased to release its 2022 Annual Report, a summary of work undertaken by the Alliance and its members this year to curb the rise of antimicrobial resista...
Read moreAMR Stewardship Prize Winner Spotlight: Ghana’s Lekma Hospital
Antimicrobial resistance, a top 10 global public health threat, is often exacerbated by the misuse and misdiagnosis of antimicrobials by patients. At Lekma Hospital, a local hospital in Accra, Ghana,...
Read moreAMR Stewardship Prize Winner Spotlight: Pakistan’s Clinical Engagement Program
Antimicrobial resistance (AMR) is a silent killer spreading across the globe at an alarming rate, leaving healthcare systems struggling to keep up. Pakistan is no exception, with limited resources and...
Read moreStrengthening the Sustainability of the Off-Patent Antibiotic Supply Chain
February 15, 2023 – The AMR Industry Alliance today announced the publication of its report, “Strengthening the Sustainability of the Off-Patent Antibiotic Supply Chain,” which investigates the...
Read moreAMR Industry Alliance Awards Annual Stewardship Prize to Lekma Hospital in Ghana and the Clinical Engagement Program in Pakistan
Prize recognizes innovative and scalable stewardship programs in low-to-moderate-income countries. Geneva – December 21, 2022 – The AMR Industry Alliance, the leading life-sciences coalition s...
Read moreSteve Brooks Speaks on Quadripartite Webinar on Ways to Prevent and Control AMR in the Environment
The Quadripartite, the Food and Agriculture Organization of the United Nations (UNFAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO) and the World Organisation...
Read moreNew Report on Drug Regulatory Approvals and the Opportunities for Antimicrobial Innovation
JULY 12, 2022 – A new report by the One Health Trust, Drug Regulatory Approvals and Opportunities for Antimicrobial Innovation - Perspectives from Brazil, India and South Africa, describes...
Read moreAMR Industry Alliance Launches Antibiotic Manufacturing Standard to Help Mitigate the Impacts of Antimicrobial Resistance
Standard provides guidance, calls on manufacturers to improve waste management programs. Geneva – June 14, 2022 – The AMR Industry Alliance, the largest life-sciences coalition set up to provide...
Read moreHealth Europa Quarterly Issue 21 Explores AMR
Health Europa Quarterly has published its twenty-first issue which features AMR, as well as the AMR Industry Alliance's Progress Report, acknowledging "the urgent need to facilitate a sustainable mark...
Read more2022 Stewardship Prize: Now Accepting Submissions
While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, limited resources exist...
Read moreStewardship Prize Winner Announced
Prize Winner: Infectious Diseases Institute - Kampala, Uganda After careful review, the AMR Industry Alliance is proud to announce the Infectious Diseases Institute (IDI) in Kampala, Uganda as the...
Read moreThomas Cueni
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “We all have a shared responsibility to find ways f...
Read moreDr. John Rex
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “Antibiotics only have a finite lifetime. We only g...
Read moreManjit Singh
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “The AMR Industry Alliance is making a next big ste...
Read moreDr. Larry Kerr
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 "Public-private partnerships are one of the invaluabl...
Read moreDr. Manica Balasegaram
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 "New treatments will only be successful if they are available t...
Read moreDr. Ramanan Laxminarayan
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “We certainly aren’t where we need to be with res...
Read moreWorld Antimicrobial Awareness Week (WAAW) 2021
As part of this year’s World Antimicrobial Awareness Week (WAAW) the AMR Industry Alliance will host a virtual panel session on Supporting the optimal use of antimicrobial medicines through inno...
Read moreRequest for Proposals: Developing a sustainability framework for off-patent antibiotics
The AMR Industry Alliance is currently seeking proposals to support the work of its Access Working Group. The duration of this consultancy is defined for a period of approximately 6 months, starting 22 October 2021 (or as soon as the procurement process is completed) and ending 28 February 2022 when the deliverables have been approved by the AMR Industry Alliance Board. The consultancy will be conducted under the overall guidance of the AMR Industry Alliance Access Working Group Lead and Core Team. The Consultancy will be home-based, from any country.
Read moreRequest for Proposals: Regulatory Landscape Phase 1
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrobial resist...
Read moreRequest for Proposals: Regulatory Landscape Phase 2
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrob...
Read moreStewardship Prize: Strengthening Stewardship and Appropriate Use in Low- and Middle-Income Countries
About the Stewardship Prize While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, limited resour...
Read moreAMR life sciences industry 2020 report: Successes and setbacks in fighting superbugs
AMR Industry Alliance reports breakthroughs in the responsible manufacturing of antibiotics and positive steps to improve how patients access and use antibiotics. But its report also highlights conc...
Read moreAMR Industry Alliance Round-Up, Issue No.3, November 2019
Welcome to the third issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as p...
Read moreAMR Industry Alliance Round-Up, Issue No.2, September 2019
Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as...
Read moreNew brochure to discover the AMR Industry Alliance in 2 minutes
Representing more than 100 biotechnology, diagnostics, generics and research-based pharmaceutical companies and associations, the AMR Industry Alliance is one of the largest private sector coalitions...
Read moreAMR Industry Alliance Round-Up, Issue No.1, June 2019
This is the first issue of "Alliance Round-Up" written for the more than 100 biotech, diagnostic, generic and pharma companies who are members of the AMR Industry Alliance, as well as people...
Read moreThe largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders
The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all st...
Read moreMultiple Alliance Members Co-sign the Canadian Declaration on Antimicrobial Resistance
The International Council of Biotechnology Associations (ICBA) supports the Canadian Declaration on Combatting Antimicrobial Resistance, signed by biopharmaceutical and diagnostic companies in Canada...
Read moreReport shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The re...
Read moreNew Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance
New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance....
Read moreAMR Roadmap Launched
Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020...
Read moreAMR Declaration Launched
More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in...
Read more